Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonazepam vs Tongue Pads in Primary Burning Mouth Syndrome
NCT04884503Phase 2Completed
- Sponsor
- Wroclaw Medical University
- Start
- Jan 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clonazepam in burning mouth syndrome (BMS), sponsored by Wroclaw Medical University. Started Jan 2019; status: completed.
02
Drugs
clonazepam
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT04884503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04884503.